Skip to content

Effectiveness of the drug Trihexyphenidyl for abnormal movements in children with Cerebral Palsy

EFFECTIVENESS OF TRIHEXYPHENIDYL FOR TREATMENT OF DYSTONIA IN CHILDREN WITH CEREBRAL PALSY

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011571
Enrollment
30
Registered
2018-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

Intervention1: open labelled intervention trial: Baseline evaluation: Following Tools would be administered to assess the severity of dystonia and motor functions. Each tool takes around 30 mins for a

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with Cerebral Palsy diagnosed as per American Academy of Neurology criteria 2006 with : 1.Presence of predominant dystonia 2.Age 6 months to 5 years

Exclusion criteria

Exclusion criteria: 1.Children who have received Trihexyphenidyl or levodopa in last 3 months. 2.Children who have required titration in their Baclofen dosage in last 3 months. 3.Poorly controlled epilepsy. 4.Diagnosed cases of Glaucoma or Congenital Heart block. 5.History of allergy or adverse reaction to anti-cholinergic drugs in the past. 6.History of orthopedic surgery or botulinum injection in last 6 months.

Design outcomes

Primary

MeasureTime frame
1.Change in score on Global Dystonia Scale 2.Change in score on Gross Motor Function Measure-88 (GMFM-88) 3.Change in score on Fine motor/perceptual sub scale of Early Developmental Profile 2 (EDP-2) Timepoint: Score will be assessed after 12 weeks that is 3months

Secondary

MeasureTime frame
1.Change in score on Global Dystonia Scale 2.Change in score on Gross Motor Function Measure-88 (GMFM-88) 3.Change in score on Fine motor/perceptual sub scale of Early Developmental Profile 2 (EDP-2) Timepoint: score will be assessed after 12 weeks that is after 3months

Countries

India

Contacts

Public ContactDr Lavanya R A

Maulana Azad Medical College

drmonicajuneja@gmail.com9968604311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026